Ilyang Pharmaceutical Co.,Ltd (007575.KS) KSC

Currency In KRW

AD

Valuation

Market Cap254.88B
Enterprise Value358.02B
P/E Ratio7.11
PEG Ratio0.08
Price/Sales Ratio0.55
Price/Book Ratio0.56
Enterprise/Revenue0.83
Enterprise/EBITDA90.02

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.07
Operating Margin-0.02
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.08

Income Statement

Revenue272.24B
Revenue/Share16,337.12
Gross Profit116.35B
EBITDA13.31B
Net Income6.9B
Diluted EPS375.42

Balance Sheet

Total Cash38.79B
Total Cash/Share2,301.39
Total Debt112.65B
Total Debt/Equity0.44
Current Ratio0.96
Book Value Per Share15,280.95

Price History

52-Week Change-51.36
52-Week High15,260
52-Week Low6,720
Moving Average 50 Days8,375
Moving Average 200 Days11,632

Statistics

Average Volume907
Shares Outstanding18.17M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate155
Trailing Annual Dividend Yield1.85
Payout Ratio0.16
Last Split Factor2:1
Last Split DateJune 28, 2006
AD